Search results

Results 1 – 6 of 6
Advanced search

Search in namespaces:

There is a page named "Bococizumab" on Wikipedia

  • Bococizumab (USAN; development code RN316) is a drug that was in development by Pfizer targeting PCSK9 to reduce LDL cholesterol. Pfizer withdrew the...
    5 KB (334 words) - 20:33, 1 December 2023
  • Thumbnail for Hypercholesterolemia
    women. Injectable antibodies against the protein PCSK9 (evolocumab, bococizumab, alirocumab) can reduce LDL cholesterol and have been shown to reduce...
    61 KB (6,215 words) - 17:45, 31 May 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    Blontress mab veterinary CD20 Blosozumab mab humanized SOST osteoporosis Bococizumab mab humanized PCSK9 dyslipidemia Brazikumab mab human IL-23 Crohn's disease...
    136 KB (4,020 words) - 07:14, 15 August 2024
  • against calcitonin gene-related peptide for the treatment of migraines Bococizumab (codenamed RN316), a monoclonal antibody against PCSK9 designed to reduce...
    7 KB (526 words) - 18:35, 30 May 2024
  • Thumbnail for PCSK9
    clinical trials as of 2014[update]. These include evolocumab (Amgen), bococizumab (Pfizer), and alirocumab (Sanofi/Regeneron Pharmaceuticals). As of July 2015[update]...
    69 KB (7,354 words) - 16:56, 11 June 2024
  • Yunis C, Shear Cl, Tardif JC. Cardiovascular efficacy and safety of bococizumab in high risk patients. N Engl J Med 2017;376:1527-1539. In these large...
    14 KB (1,601 words) - 08:31, 24 January 2024